3SBio Inc.
TRSBF
$0.80
$0.03784.96%
Weiss Ratings | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | C+ | |||
Rating Factors | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Excellent | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.00 | |||
Price History | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.00% | |||
60-Day Total Return | 0.00% | |||
90-Day Total Return | 0.00% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | 0.00% | |||
2-Year Total Return | 0.00% | |||
3-Year Total Return | -44.06% | |||
5-Year Total Return | -66.94% | |||
52-Week High % Change | 0.00% | |||
52-Week Low % Change | 0.00% | |||
Price | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.80 | |||
52-Week Low Price | $0.80 | |||
52-Week Low Price (Date) | Sep 29, 2023 | |||
52-Week High Price (Date) | Sep 29, 2023 | |||
Valuation | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $2.01B | |||
Enterprise Value | 2.11B | |||
Price/Earnings (TTM) | 7.25 | |||
Earnings Per Share (TTM) | 0.11 | |||
Earnings Per Share Growth | 8.78% | |||
Price/Earnings To Growth | 0.83 | |||
Price/Sales (TTM) | 1.80 | |||
Price/Book (Q) | 1.03 | |||
Enterprise Value/Revenue (TTM) | 1.89 | |||
Price | $0.80 | |||
Enterprise Value/EBITDA (TTM) | 5.32 | |||
Enterprise Value/EBIT | 6.09 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 2.444B | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | 21.41% | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 86 24 2538 6000 | |||
Address | -- | |||
Website | www.3sbio.com | |||
Country | China | |||
Year Founded | 1993 | |||
Profitability | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 30.99% | |||
Profit Margin | 25.70% | |||
Management Effectiveness | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 6.73% | |||
Return on Equity | 12.92% | |||
Income Statement | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $1.09B | |||
Total Revenue (TTM) | $1.09B | |||
Revenue Per Share | $0.45 | |||
Gross Profit (TTM) | $907.99M | |||
EBITDA (TTM) | $385.57M | |||
EBIT (TTM) | $336.91M | |||
Net Income (TTM) | $279.36M | |||
Net Income Avl. to Common (TTM) | $279.36M | |||
Total Revenue Growth (Q YOY) | 15.27% | |||
Earnings Growth (Q YOY) | -2.42% | |||
EPS Diluted (TTM) | $0.11 | |||
EPS Diluted Growth (Q YOY) | -1.06% | |||
Balance Sheet | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $920.16M | |||
Cash Per Share (Q) | $0.38 | |||
Total Current Assets (Q) | $1.41B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $2.20B | |||
Current Ratio (Q) | 2.576 | |||
Book Value Per Share (Q) | $0.78 | |||
Total Assets (Q) | $3.19B | |||
Total Current Liabilities (Q) | $548.80M | |||
Total Debt (Q) | $685.50M | |||
Total Liabilities (Q) | $993.55M | |||
Total Common Equity (Q) | $1.86B | |||
Cash Flow | TRSBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$476.33M | |||
Cash from Financing (TTM) | $4.86M | |||
Net Change in Cash (TTM) | -$123.29M | |||
Levered Free Cash Flow (TTM) | $18.86M | |||
Cash from Operations (TTM) | $329.82M | |||